These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 11910573)

  • 1. Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt.
    Russo MW; Jacques PF; Mauro M; Odell P; Brown RS
    Liver Transpl; 2002 Mar; 8(3):271-7. PubMed ID: 11910573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding.
    Bañares R; Casado M; Rodríguez-Láiz JM; Camúñez F; Matilla A; Echenagusía A; Simó G; Piqueras B; Clemente G; Cos E
    Am J Gastroenterol; 1998 Jan; 93(1):75-9. PubMed ID: 9448179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality.
    Russo MW; Sood A; Jacobson IM; Brown RS
    Am J Gastroenterol; 2003 Nov; 98(11):2521-7. PubMed ID: 14638358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
    Membreno F; Baez AL; Pandula R; Walser E; Lau DT
    J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension using memotherm stents: a prospective multicenter study.
    Domagk D; Patch D; Dick R; Grosso M; Rousseau H; Otal P; Goffette P; Heinecke A; Drees M; Domschke W; Menzel J
    Cardiovasc Intervent Radiol; 2002; 25(6):506-12. PubMed ID: 12183763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case-control study of transjugular intrahepatic portosystemic stent shunts for patients admitted to intensive care following variceal bleeding.
    Corbett C; Murphy N; Olliff S; Mangat KS; Tripathi D
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):344-51. PubMed ID: 23354162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIPS for treatment of variceal hemorrhage: clinical outcomes in 128 patients at a single institution over a 12-year period.
    Gaba RC; Omene BO; Podczerwinski ES; Knuttinen MG; Cotler SJ; Kallwitz ER; Berkes JL; Walzer NM; Bui JT; Owens CA
    J Vasc Interv Radiol; 2012 Feb; 23(2):227-35. PubMed ID: 22178037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predicting survival after transjugular intrahepatic portosystemic shunt creation: 15 years' experience from a single tertiary medical center.
    Pan JJ; Chen C; Caridi JG; Geller B; Firpi R; Machicao VI; Hawkins IF; Soldevila-Pico C; Nelson DR; Morelli G
    J Vasc Interv Radiol; 2008 Nov; 19(11):1576-81. PubMed ID: 18789725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of early mortality after transjugular intrahepatic portosystemic shunt creation for the treatment of refractory ascites.
    Harrod-Kim P; Saad WE; Waldman D
    J Vasc Interv Radiol; 2006 Oct; 17(10):1605-10. PubMed ID: 17057001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transjugular intrahepatic portosystemic shunts for refractory ascites after liver transplantation.
    Abouljoud M; Yoshida A; Kim D; Jerius J; Arenas J; Raoufi M; Brown K; Moonka D
    Transplant Proc; 2005 Mar; 37(2):1248-50. PubMed ID: 15848685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.
    Ochs A; Rössle M; Haag K; Hauenstein KH; Deibert P; Siegerstetter V; Huonker M; Langer M; Blum HE
    N Engl J Med; 1995 May; 332(18):1192-7. PubMed ID: 7700312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy.
    Kochar N; Tripathi D; Ireland H; Redhead DN; Hayes PC
    Gut; 2006 Nov; 55(11):1617-23. PubMed ID: 16571635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
    Saad WE; Darwish WM; Davies MG; Waldman DL
    J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.
    Barrio J; Ripoll C; Bañares R; Echenagusia A; Catalina MV; Camúñez F; Simó G; Santos L
    Eur J Radiol; 2005 Jul; 55(1):120-4. PubMed ID: 15950109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transjugular intrahepatic portosystemic shunt for liver transplantation.
    Zhou GW; Cai WY; Li HW; Zhu Y; Dodson F; Fung JJ
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):179-82. PubMed ID: 14607734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transjugular intrahepatic portosystemic shunts: long-term patency and clinical results in a patient cohort observed for 3-9 years.
    ter Borg PC; Hollemans M; Van Buuren HR; Vleggaar FP; Groeneweg M; Hop WC; Laméris JS
    Radiology; 2004 May; 231(2):537-45. PubMed ID: 15044746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial.
    Henderson JM; Boyer TD; Kutner MH; Galloway JR; Rikkers LF; Jeffers LJ; Abu-Elmagd K; Connor J;
    Gastroenterology; 2006 May; 130(6):1643-51. PubMed ID: 16697728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.
    Malinchoc M; Kamath PS; Gordon FD; Peine CJ; Rank J; ter Borg PC
    Hepatology; 2000 Apr; 31(4):864-71. PubMed ID: 10733541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.